6
Views
0
CrossRef citations to date
0
Altmetric
Research

Crystalline lens clarity in patients treated with isotretinoin

ORCID Icon, ORCID Icon, , & ORCID Icon
Received 05 Feb 2024, Accepted 18 Jun 2024, Published online: 24 Jun 2024

References

  • Bagatin E, Costa CS. The use of isotretinoin for acne–an update on optimal dosing, surveillance, and adverse effects. Expert Rev Clin Pharmacol 2020; 13: 885–897. doi:10.1080/17512433.2020.1796637.
  • Bauer LB, Ornelas JN, Elston DM et al. Isotretinoin: controversies, facts, and recommendations. Expert Rev Clin Pharmacol 2016; 9: 1435–1442. doi:10.1080/17512433.2016.1213629.
  • On SC, Zeichner J. Isotretinoin updates. Dermatol Ther 2013; 26: 377–389. doi:10.1111/dth.12084.
  • Dessinioti C, Zouboulis CC, Bettoli V et al. Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin. J Eur Acad Dermatol Venereol 2020; 34: 2229–2240. doi:10.1111/jdv.16430.
  • Li C, McFadden SA, Morgan I et al. All-trans retinoic acid regulates the expression of the extracellular matrix protein fibulin-1 in the guinea pig sclera and human scleral fibroblasts. Mol Vis 2010; 16: 689–697.
  • Yan DS, Zhou XT, Chen XY et al. Expression of retinoid acid receptors in human scleral fibroblasts and regulation of growth of fibroblasts by retinoic acid. Zhonghua Yan Ke Za Zhi 2007; 43: 750–753.
  • Huang J, Qu XM, Chu RY. Expressions of cellular retinoic acid binding proteins I and retinoic acid receptor-β in the guinea pig eyes with experimental myopia. Int J Ophthalmol 2011; 4: 131–136. doi:10.3980/j.issn.2222-3959.2011.02.04.
  • Kimura K, Zhou H, Orita T et al. Suppression by an RAR-γ agonist of collagen degradation mediated by corneal fibroblasts. Invest Ophthalmol Vis Sci 2017; 58: 2250–2257. doi:10.1167/iovs.15-18701.
  • Kimura K, Zhou H, Orita T et al. Inhibition by all-trans retinoic acid of collagen degradation mediated by corneal fibroblasts. Clin Exp Ophthalmol 2016; 44: 502–508. doi:10.1111/ceo.12709.
  • Bitzer M, Feldkaemper M, Schaeffel F. Visually induced changes in components of the retinoic acid system in fundal layers of the chick. Exp Eye Res 2000; 70: 97–106. doi:10.1006/exer.1999.0762.
  • Hori Y, Spurr-Michaud SJ, Russo CL et al. Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci 2005; 46: 4050–4061. doi:10.1167/iovs.05-0627.
  • Egger SF, Huber-Spitzy V, Böhler K et al. Ocular side effects associated with 13-cis-retinoic acid therapy for acne vulgaris: clinical features, alterations of tearfilm and conjunctival flora. Acta Ophthalmol Scand 1995; 73: 355–357. doi:10.1111/j.1600-0420.1995.tb00043.x.
  • Karalezli A, Borazan M, Altinors DD et al. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin. Cornea 2009; 28: 46–50. doi:10.1097/ICO.0b013e318183a396.
  • Sekeryapan B, Dılek N, Oner V et al. Retinal nerve fiber layer and ganglion cell layer thickness in patients receiving systemic isotretinoin therapy. Int Ophthalmol 2013; 33: 481–484. doi:10.1007/s10792-013-9726-6.
  • Demirok G, Topalak Y, Gündüz Ö et al. The long-term effect of oral isotretinoin therapy on macula ganglion cell complex thickness. Cutan Ocul Toxicol 2017; 36: 259–262. doi:10.1080/15569527.2016.1265549.
  • Yılmaz U, Küçük E, Koç Ç et al. Investigation of the effects of systemic isotretinoin treatment on retinal nerve fiber layer and macula. J Dermatolog Treat 2017; 28: 314–317. doi:10.1080/09546634.2016.1254146.
  • Moy A, McNamara NA, Lin MC. Effects of isotretinoin on meibomian glands. Optom Vis Sci 2015; 92: 925–930. doi:10.1097/OPX.0000000000000656.
  • Yuksel N, Ozer MD, Akcay E et al. Reduced central corneal thickness in patients with isotretinoin treatment. Cutan Ocul Toxicol 2015; 34: 318–321. doi:10.3109/15569527.2014.990155.
  • Cumurcu T, Sener S, Ozsoy E et al. Changes in anterior chamber parameters with the Pentacam rotating Scheimpflug and axial length measurements by ultrasound in patients who use isotretinoin. Curr Eye Res 2012; 37: 395–398. doi:10.3109/02713683.2011.635399.
  • Ozyol P, Ozyol E, Yildirim FE. Remodeling of cornea with isotretinoin treatment. Eye Contact Lens 2021; 47: 366–371. doi:10.1097/ICL.0000000000000769.
  • Herman DC, Dyer JA. Anterior subcapsular cataracts as a possible adverse ocular reaction to isotretinoin. Am J Ophthalmol 1987; 103: 236–237. doi:10.1016/S0002-9394(14)74237-0.
  • Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol 1997; 36: 416–418. doi:10.1046/j.1365-4362.1997.00099.x.
  • Keleş A, Doğuizi S, Şahin NM et al. Anterior segment findings in patients with osteogenesis imperfecta: a case-control study. Cornea 2020; 39: 935–939. doi:10.1097/ICO.0000000000002345.
  • Doğuizi S, Özateş S, Hoşnut FÖ et al. Assessment of corneal and lens clarity in children with Wilson disease. J AAPOS 2019; 23: e147.1–.e147.8. doi:10.1016/j.jaapos.2018.12.010.
  • Tekin K, Sekeroglu MA, Kiziltoprak H et al. Corneal densitometry in healthy corneas and its correlation with endothelial morphometry. Cornea 2017; 36: 1336–1342. doi:10.1097/ICO.0000000000001363.
  • Cook CS, Sulik KK. Keratolenticular dysgenesis (Peters’ anomaly) as a result of acute embryonic insult during gastrulation. J Pediatr Ophthalmol Strabismus 1988; 25: 60–66. doi:10.3928/0191-3913-19880301-04.
  • Cook CS, Sulik KK. Laminin and fibronectin in retinoid-induced keratolenticular dysgenesis. Invest Ophthalmol Vis Sci 1990; 31: 751–757.
  • Bayrak G, Özdamar Erol Y, Kazanci B. An objective evaluation of crystalline lens density using Scheimpflug lens densitometry in different uveitis entities. Int Ophthalmol 2020; 40: 2031–2040. doi:10.1007/s10792-020-01379-4.
  • Kirkwood BJ, Hendicott PL, Read SA et al. Repeatability and validity of lens densitometry measured with Scheimpflug imaging. J Cataract Refract Surg 2009; 35: 1210–1215. doi:10.1016/j.jcrs.2009.03.017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.